OIS XV is the comprehensive gathering for the entire eye care ecosystem, spanning retina, glaucoma, anterior segment, drug delivery, and beyond. This day and a half program features innovation showcases, investor spotlights, and strategic discussions that bring together leading startups, global strategics, and clinical experts.
AGENDA - FRIDAY, NOVEMBER 21, 2025
7:30 – 8:25 AM
Check-in and Networking Breakfast
8:25 – 8:30 AM
Welcome & Opening Remarks
Presented By:
Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island
8:35 - 9:45 AM
New Innovation Showcase
IDE Group | Richard Sokolov, Director IDE Medical Devices
Signal12 | Tom Mitro, President & CEO
Perfuse Therapeutics | Sevgi Gurkan, MD, Founder, CEO and President
Cloudbreak Pharma | Abu Abraham, MD, Chief Medical Officer
CS Pharmaceuticals Limited | Rod Hafner, Chief Development Officer
Eyexora | Theresa Heah, MD, MBA, CEO and Vice Chair
PulseMedica | Nir Katchinskiy, Co-Founder & CEO
Oro Therapeutics | Matt Smith, CEO & Co-Founder
InnSight Technologies | LeAnne Labriola, DO, MBA, Founder & CEO
Irenix | Stephen Smith, MD, CEO
9:45 - 10:45 AM
Innovating Together: Driving Solutions for Ophthalmic Challenges with CCOI – Collaborative Community on Ophthalmic Innovation
Panelists:
Natalie Afshari, MD, FACS, Professor of Ophthalmology and Chief of Cornea and Refractive Surgery - UC San Diego Shiley Eye Institute
Mark Blumenkranz, MD, Byers Eye Institute at Stanford University School of Medicine
Malvina Eydelman, MD, CEO - The Collaborative Community on Ophthalmic Innovation
Daniela Ferrara, MD, MS, PhD, FASRS, CMO - Topcon
Ash Kras, MD, Sydney Eye Hospital Foundation
Vinit Mahajan, MD, PhD, Stanford University Professor of Ophthalmology, Vice Chair for Research
David Myung, MD, PhD, Associate Professor of Ophthalmology - Byers Eye Institute at Stanford University School of Medicine
10:45 - 11:15 AM
Networking Break
11:15 - 12:10 PM
Drug Delivery Showcase
Valitor | Wesley Jackson, PhD, President & Chief Scientific Officer
Uneedle | Sven Mentink, Director, Ophthalmology
Everads Therapy | Moshe Weinstein, CEO
Nanodropper | Mackenzie Andrews, Chief Commercial Officer
OcuMedic | Keith D. Ignotz, MBA, President & CEO
Re-Vana Therapeutics | Michael O'Rourke, CEO
Eye-Go | Henrik Nagel, CEO
12:10 - 1:00 PM
AI and Diagnostics Showcase
Overview
Presented By:
Daniela Ferrara, MD PhD FASRS, CMO - Topcon
Sanro Health | Ash Kras, MD, Founder & CEO
VIDEANT | Grace Chang, MD, PhD, CEO & Founder
Zilia | Dominic Sauvageau, CTO
ClinOmics.AI | Vinit Mahajan, MD, PhD, Co-founder & Chief Scientific Advisor
Evoq Technologies | Daniel Lindgren, Co-Founder & CEO
1:00 - 1:50 PM
Networking Lunch
1:50 - 2:30 PM
Investor Insights
Participants:
Hannah Chang, MD, PhD, Managing Director - Platanus Ventures
Jeffrey Friedman, MD, PhD, Friedman Bioventure
Garrett Hamontree, Partner - Visionary Ventures
Joe Markson, PhD, Principal - Novo Holdings
Moderated By:
Adrienne Graves, PhD, Independent Director, Public and Private Biotech/Pharma Companies - Board Chair, RD Fund - Former CEO, Santen Inc - Fomer Chair, Iveric Bio
2:30 – 3:40 PM
Regenerative Therapies Showcase
Precise Bio | Lior Shav, Head of Business Development
Claris Biotherapeutics | Clarke Atwell, CEO
Diorasis Therapeutics | Remis Bistras, CEO
Adverum Biotechnologies | Laurent Fischer, MD, CEO
REGENXBIO | Steve Pakola, MD, CMO
Ray Therapeutics | Peter Francis, MD, PhD, Chief Medical and Scientific Officer
4DMT | Chris Simms, Chief Commercial Officer
Emmecell | Jeffrey Goldberg, MD, PhD, Co-founder and Director, Board of Managers
3:40 – 4:10 PM
Networking Break
4:10 – 4:45 PM
Glaucoma Innovation
Panelists:
Jeffrey Goldberg, MD, PhD, Professor and Chair of Ophthalmology - Byers Eye Institute
Shawn O'Neil, CEO - Vialase
Jai G Parekh, MD, MBA, Chief Commercial Officer - Nordic Pharma Eye Care /Co-Founder, EyeCare Consultants of NJ
Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island
Moderated By:
Barbara Wirostko, MD, FARVO, CMO & Co-Founder - Qlaris Bio / Co-founder & Medical Advisor - MyEyes / Clinical Adjunct Professor - University of Utah, Moran Eye Center
4:45 – 5:35 PM
OIS Situation Room
Panelists:
Amy Hopkin, PhD, Director, Search and Evaluation for Eye Care - AbbVie External Innovation
Shannon Spock, Pharmaceutical Search and Evaluation Head, BD&L – Alcon
Kim Smith, Founder & CIO – Ausangate Capital
Moderated By:
Ram Palanki, PharmD, Executive Vice President & Chief Commercial Officer - REGENXBIO
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group
5:35 - 7:00 PM
Networking Reception
AGENDA - SATURDAY, NOVEMBER 22, 2025
7:45 - 8:25 AM
Networking Breakfast
8:25 - 8:30 AM
Opening Remarks
8:30 – 9:40 AM
Anterior Innovation Showcase
ECI Therapeutics | Elan Weiner, CEO
OKYO Pharma | Gary S. Jacob, PhD, CEO
Theialife | Patricia Zilliox, PhD, Advisor
BostonSight | Daniel Brocks, MD, CMO
Azalea Vision | Enrique Vega, CEO & Co-Founder
AdOM Advanced Optical Methods | Stan Miele, CEO
Horizon Surgical Systems | JP Hubschman, MD, PhD, CEO
Opus Genetics | Jay Pepose, MD, PhD, Chief Medical Officer
Stuart Therapeutics | Eric Schlumpf, President & CEO
9:40 - 10:15 AM
Refractive Renaissance: The Next Wave in Presbyopia and Accommodative Solutions
Panelists:
Milton Hom, OD, Canyon City Eye Care
Alex Lopez, COO - Ace Vision Group
Eef Schimmelpennink, President & CEO - Lenz Therapeutics
Eric Weinberg, Co-President and Chief Commercial Officer - RxSight
Moderated By:
Ehsan Sadri, MD, Founder - Visionary Eye Institute
10:15- 10:45 AM
Morning Networking Break
10:45 - 12:05 PM
Retina Innovation Showcase
AiViva BioPharma | Diane Tang-Liu, PhD, President & CEO
Oculis | Riad Sherif, MD, CEO
Galimedix Therapeutics | Alexander Gebauer, MD, PhD, Executive Chairman
Neurotech Pharmaceuticals | Rich Small, CEO
FELIQS | Kenichiro Kuninobu, PhD, Co-Founder & CEO
Ocudyne | Jeff Franco, CEO
Ripple Therapeutics | Tom Reeves, Co-founder, President & CEO
Novaliq | Christian Roesky, PhD, CEO
ForwardVue | Bob Katz, CEO
Surrozen | Dan Chao, MD, PhD, Vice President and Head of Clinical Development
OD-OS | Jan Tode, MD, CMO
12:05 – 12:40 PM
The Future Outlook of Dry AMD: One Disease or Many?
Panelists:
Mayssa Attar, MD, PhD, B+L
Michael Ackermann, PhD, Founder & CEO - Osanni Bio
Baruch Kuppermann, MD, PhD, Steinert Professor and Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute - University of California
Reza Safaei, MD, Senior Vice President, Medical Affairs International - Apellis Pharmaceuticals
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Executive Chairman - Eyconis / Senior Partner - HealthQuest Capital Management
12:40 - 1:15 PM
Redefining Value: What Will Matter Most in the Next Decade
Panelists:
Gordon Bethwaite, Head of Marketing, Eye Care - Viatris
Wayne Caulder, VP & GM, Surgical (US/Canada), Bausch + Lomb
Doug Faunce, PhD, Executive Director - Head of Search and Evaluation for Eye Care, AbbVie Ventures
David LeCause, Former Vice President Allergan Eye Care Business Unit; Strategic Advisor - Ophthalmic Pharmaceuticals I Biotech I Drug Delivery I Med Device
Moderated By:
Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island
1:15 - 1:25 PM